跳至主要内容
临床试验/NCT03395561
NCT03395561Unknown不适用

the Evaluation of Green Coffee Extract Supplementation on Adropin, Irisin, Vaspine,Systemic Inflammation and Oxidative Stress in Breast Cancer Survivors

National Nutrition and Food Technology Institute1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年2月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Interleukin 6

研究概览

简要总结

To study the effects of green coffee supplement on adropin, irisin, vaspine, systemic inflammation and oxidative stress in breast cancer survivors.50 breast cancer survivors who their treatment is over and referred to follow breast cancer clinic with will be randomly allocated to receive placebos or 2 capsules green coffe for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, adropin, irisin, vaspine, systemic inflammation and oxidative stress will be assessed and compared between groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age of 18 to 70 years
  • Body Mass Index (BMI) between 25-40 treatment is over

排除标准

  • Taking any kind of supplement for weight reduction
  • pregnancy or lactation
  • Professional athletes

研究组 & 干预措施

green coffe

Active Comparator

2 capsuls of green coffe

干预措施: green coffee (Dietary Supplement)

control

Placebo Comparator

2 capsuls

干预措施: control (Other)

结局指标

主要结局

Interleukin 6

时间窗: 12 weeks

assessed by ELISA

Tumor necrosis factor alpha

时间窗: 12 weeks

assessed by ELISA

次要结局

  • body mass index(12 weeks)

研究者

发起方
National Nutrition and Food Technology Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Azita Hekmatdoost

Principal Investigator

National Nutrition and Food Technology Institute

研究点 (1)

Loading locations...

相似试验